Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:03 PM
Ignite Modification Date:
2025-12-24 @ 3:03 PM
NCT ID:
NCT00475059
Eligibility Criteria:
Inclusion Criteria:
* Kidney transplantation \> 1 year
* Patient with immunosuppressant treatment of TACROLIMUS (PROGRAF)
* Creatinine clearance \> 30 ml/min/1,73m2 within 3 months before inclusion
* Written informed consent
* Patient affiliated to social insurance
Exclusion Criteria:
* Unstable renal function defined by serum creatinine (J0) \> 25% serum creatinine realised in 3 months
* Treatment: Bactrim, Fansidar, Cimetidine arrow within the week before inclusion
* Contraindication listed in the labeling of Cimetidine arrow
* Last residual rate of Tacrolimus \> 12 ng/ml.
* Treatment : carvedilol, phenytoïn (interaction with cimetidine)
* Serious hepatic insufficiency
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00475059
Study Brief:
Protocol Section:
NCT00475059